0001104659-24-063903.txt : 20240521
0001104659-24-063903.hdr.sgml : 20240521
20240521170437
ACCESSION NUMBER: 0001104659-24-063903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chaturvedi Pravin R
CENTRAL INDEX KEY: 0001916935
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 24970526
MAIL ADDRESS:
STREET 1: C/O JAGUAR HEALTH INC., 200 PINE STREET
STREET 2: SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-371-8300
MAIL ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
tm2414996-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-17
0
0001585608
Jaguar Health, Inc.
JAGX
0001916935
Chaturvedi Pravin R
C/O JAGUAR HEALTH, INC.
200 PINE STREET, SUITE 400
SAN FRANCISCO
CA
94104
0
1
0
0
Chief Scientific Officer
0
Common Stock
2024-05-17
4
M
0
871
A
2141
D
Restricted stock units
2024-05-17
4
M
0
871
0
D
Common Stock
871
871
D
Restricted stock units convert into common stock on a one-for-one basis.
On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock.
The restricted stock units were originally approved by the issuer's board of directors on March 28, 2022 and previously reported as covering 195,934 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.
/s/ Jonathan Wolin, Attorney-in-Fact
2024-05-21